Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Andrew Portell et al.|Cell|2018Cited by 2k
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Nir Hacohen, Yunxin J. Jiao et al.|Nature Communications|2017Cited by 999
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Mikaël J. Pittet, Pratyaksha Wirapati et al.|Science|2023Cited by 618
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Daniel A. Haber, Whijae Roh et al.|Cancer Discovery|2020Cited by 229
Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, María P. Roberti et al.|Nature Communications|2017Cited by 201